Hepatitis B vaccination in HIV-infected adults: current evidence, recommendations and practical considerations (Q37587663)

21 August 2017

1 reference

title

Hepatitis B vaccination in HIV-infected adults: current evidence, recommendations and practical considerations (English)

1 reference

21 August 2017

0 references

1 reference

3

H M Crane

1 reference

21 August 2017

H N Kim

1

1 reference

21 August 2017

R D Harrington

2

1 reference

21 August 2017

S Dhanireddy

4

1 reference

21 August 2017

T H Dellit

5

1 reference

21 August 2017

D H Spach

6

1 reference

21 August 2017

language of work or name

1 reference

1 September 2009

1 reference

International Journal of STD & AIDS

21 August 2017

1 reference

21 August 2017

20

1 reference

21 August 2017

9

1 reference

21 August 2017

595-600

1 reference

Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects

21 August 2017

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009126

Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009126

Outcome of Hepatitis B Virus Infection in Homosexual Men and Its Relation to Prior Human Immunodeficiency Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009126

Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009126

HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009126

Hepatitis B Vaccine in Health Care Personnel: Safety, lmmunogenicity, and Indicators of Efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009126

Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009126

Immune responses in patients with HIV infection after vaccination with recombinant Hepatitis B virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009126

Humoral response to hepatitis B vaccination and its relationship with T CD45RA+ (naïve) and CD45RO+ (memory) subsets in HIV-1-infected subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009126

Independent clinical predictors of impaired response to hepatitis B vaccination in HIV-infected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009126

Immunological response to hepatitis B vaccination in patients with AIDS and virological response to highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009126

Serologic response to hepatitis B vaccine in HIV infected and high-risk HIV uninfected adolescents in the REACH cohort. Reaching for Excellence in Adolescent Care and Health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009126

A prospective open study of the efficacy of high-dose recombinant hepatitis B rechallenge vaccination in HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009126

The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009126

Response to hepatitis B vaccination in a primary care setting: influence of HIV infection, CD4+ lymphocyte count and vaccination schedule

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009126

Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009126

Intradermal recombinant hepatitis B vaccine for healthcare workers who fail to respond to intramuscular vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009126

Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009126

Efficacy of granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant for hepatitis B virus in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009126

CPG 7909 adjuvant plus hepatitis B virus vaccination in HIV-infected adults achieves long-term seroprotection for up to 5 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009126

Evolution of Hepatitis B Serological Markers in HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009126

Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009126

Occult hepatitis B in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009126

Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009126

Prevalence and long-term effects of occult hepatitis B virus infection in HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009126

Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implications in hepatitis B vaccination programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009126

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009126

Hepatitis A and B Vaccination Practices for Ambulatory Patients Infected with HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.009126

21 January 2018

Identifiers

DOI

10.1258/IJSA.2009.009126

1 reference

release_n42yoykbpnggxfhsvnmql4d7vy

21 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/n42yoykbpnggxfhsvnmql4d7vy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference